107 related articles for article (PubMed ID: 9613109)
1. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
2. [Combination of antisense human telomerase RNA and antisense human telomerase catalytic subunit inhibits cervical cancer Hela cells growth].
Lei LX; Chen ZD
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):42-6. PubMed ID: 15774092
[TBL] [Abstract][Full Text] [Related]
3. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
5. Stable expression of antisense hTR inhibits in vitro pancreatic cancer cell growth.
Teng L; Chen S; Thomas J F
Chin Med J (Engl); 2002 Aug; 115(8):1196-200. PubMed ID: 12215291
[TBL] [Abstract][Full Text] [Related]
6. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA.
Koga S; Kondo Y; Komata T; Kondo S
Gene Ther; 2001 Apr; 8(8):654-8. PubMed ID: 11320413
[TBL] [Abstract][Full Text] [Related]
8. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells.
Yatabe N; Kyo S; Kondo S; Kanaya T; Wang Z; Maida Y; Takakura M; Nakamura M; Tanaka M; Inoue M
Cancer Gene Ther; 2002 Jul; 9(7):624-30. PubMed ID: 12082463
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA.
Kondo S; Kondo Y; Li G; Silverman RH; Cowell JK
Oncogene; 1998 Jun; 16(25):3323-30. PubMed ID: 9681832
[TBL] [Abstract][Full Text] [Related]
11. Can inhibition of telomerase increase pancreatic cancer cell's susceptibility to chemotherapeutic reagents?
Teng LS; Fahey TJ
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):155-60. PubMed ID: 14607648
[TBL] [Abstract][Full Text] [Related]
12. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component.
Kondo Y; Koga S; Komata T; Kondo S
Oncogene; 2000 Apr; 19(18):2205-11. PubMed ID: 10822370
[TBL] [Abstract][Full Text] [Related]
13. [Cleavage of telomerase RNA component by two DNAzymes and their effects on expression of two apoptosis-related genes in human mammary cancer cells].
Zhao JM; Li MY; Yang Z; Li Z; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):638-42. PubMed ID: 15958297
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
Hayashidani Y; Hiyama E; Murakami Y; Sueda T
Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
[TBL] [Abstract][Full Text] [Related]
15. Delivering antisense telomerase RNA by a hybrid adenovirus/ adeno-associated virus significantly suppresses the malignant phenotype and enhances cell apoptosis of human breast cancer cells.
Zhang X; Chen Z; Chen Y; Tong T
Oncogene; 2003 Apr; 22(16):2405-16. PubMed ID: 12717417
[TBL] [Abstract][Full Text] [Related]
16. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
[TBL] [Abstract][Full Text] [Related]
17. Antisense telomerase induced cell growth inhibition, cell cycle arrest and telomerase activity down-regulation in gastric and colon cancer cells.
Wong SC; Yu H; Moochhala SM; So JB
Anticancer Res; 2003; 23(1A):465-9. PubMed ID: 12680250
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human telomerase activity by peptide nucleic acids.
Norton JC; Piatyszek MA; Wright WE; Shay JW; Corey DR
Nat Biotechnol; 1996 May; 14(5):615-9. PubMed ID: 9630953
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
[TBL] [Abstract][Full Text] [Related]
20. [Effects of antisense human telomerase RNA on growth of human gastric cancer cells].
Zhang F; Zhang X; Fan D; Deng Z; Yan y ; Wu H
Zhonghua Bing Li Xue Za Zhi; 2000 Oct; 29(5):367-9. PubMed ID: 11866938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]